Tokyo Tape
Sign in
← ReproCELL

Half-year report · Q2

4978.TEDINET S100UOVO
Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 43
MetricValuePeriodScopeSource row
Revenue¥1.3bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥2.4bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥1.1bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income−¥149m2024-04-01 → 2024-09-30Cons.Operating income
Operating income−¥242m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income−¥103m2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥40m2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥70m2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax−¥103m2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥62m2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)−¥104m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥31m2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥61m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income−¥104m2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥61m2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥9.4bnat 2024-09-30Cons.Assets
Total assets¥9.1bnat 2024-03-31Cons.Assets
Total assets¥8.4bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥679mat 2024-09-30Cons.Liabilities
Total liabilities¥741mat 2024-03-31Cons.Liabilities
Net assets / equity¥8.7bnat 2024-09-30Cons.Net assets
Net assets / equity¥8.3bnat 2024-03-31Cons.Net assets
Net assets / equity¥7.7bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥3.0bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥2.9bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥3.0bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.9bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow−¥131m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥11m2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥58m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥412m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥404m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥46m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥681m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥544m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥-1.142024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-0.372023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.712023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio92.8%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio91.8%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio92.1%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment ordinary income2024-04-01 → 2024-09-30−¥378m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥176m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥176m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentsegment ordinary income2024-04-01 → 2024-09-30¥8m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥1.1bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.1bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentsegment ordinary income2024-04-01 → 2024-09-30¥267m
—segment totalrevenue2024-04-01 → 2024-09-30¥1.3bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥1.3bn
—segment totalsegment ordinary income2024-04-01 → 2024-09-30¥275m
Reconciling Itemsreconcilingsegment ordinary income2023-04-01 → 2023-09-30−¥214m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥122m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥122m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentsegment ordinary income2023-04-01 → 2023-09-30¥110m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentsegment ordinary income2023-04-01 → 2023-09-30¥174m
—segment totalrevenue2023-04-01 → 2023-09-30¥1.1bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥1.1bn
—segment totalsegment ordinary income2023-04-01 → 2023-09-30¥284m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 483
ItemContextValueUnit
Asset retirement obligations nclPrior1YearInstant8969000JPY
Asset retirement obligations nclCurrentQuarterInstant9036000JPY
Other nclPrior1YearInstant－JPY
Other nclCurrentQuarterInstant647000JPY
Noncurrent liabilitiesPrior1YearInstant62630000JPY
Noncurrent liabilitiesCurrentQuarterInstant37018000JPY
LiabilitiesPrior1YearInstant741033000JPY
LiabilitiesCurrentQuarterInstant679499000JPY
Capital stockPrior1YearInstant2322198000JPY
Capital stockCurrentQuarterInstant2663963000JPY
Capital surplusPrior1YearInstant6380081000JPY
Capital surplusCurrentQuarterInstant6219921000JPY
Retained earningsPrior1YearInstant-546875000JPY
Retained earningsCurrentQuarterInstant-149170000JPY
Treasury stockPrior1YearInstant-916000JPY
Treasury stockCurrentQuarterInstant-916000JPY
Shareholders equityPrior1YearInstant8154487000JPY
Shareholders equityCurrentQuarterInstant8733797000JPY
Valuation difference on available for sale securitiesPrior1YearInstant135651000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant17947000JPY
Foreign currency translation adjustmentPrior1YearInstant18034000JPY
Foreign currency translation adjustmentCurrentQuarterInstant-9288000JPY
Valuation and translation adjustmentsPrior1YearInstant153686000JPY
Valuation and translation adjustmentsCurrentQuarterInstant8659000JPY
Subscription rights to sharesPrior1YearInstant3419000JPY
Subscription rights to sharesCurrentQuarterInstant601000JPY
Net assetsPrior1YearInstant8311593000JPY
Net assetsCurrentQuarterInstant8743058000JPY
Liabilities and net assetsPrior1YearInstant9052627000JPY
Liabilities and net assetsCurrentQuarterInstant9422557000JPY
Net sales of finished goods rev oaPrior1YTDDuration686969000JPY
Net sales of finished goods rev oaCurrentYTDDuration734409000JPY
Service revenue rev oaPrior1YTDDuration460170000JPY
Service revenue rev oaCurrentYTDDuration586004000JPY
Net salesPrior1YTDDuration1147139000JPY
Net salesCurrentYTDDuration1320413000JPY
Cost of finished goods soldPrior1YTDDuration423787000JPY
Cost of finished goods soldCurrentYTDDuration377503000JPY
Cost of service operations cosPrior1YTDDuration224511000JPY
Cost of service operations cosCurrentYTDDuration236290000JPY
Cost of salesPrior1YTDDuration648299000JPY
Cost of salesCurrentYTDDuration613794000JPY
Gross profitPrior1YTDDuration498840000JPY
Gross profitCurrentYTDDuration706619000JPY
Research and development expenses sgaPrior1YTDDuration167266000JPY
Research and development expenses sgaCurrentYTDDuration236622000JPY
Other selling general and administrative expenses sgaPrior1YTDDuration573138000JPY
Other selling general and administrative expenses sgaCurrentYTDDuration619173000JPY
Selling general and administrative expensesPrior1YTDDuration740405000JPY
Selling general and administrative expensesCurrentYTDDuration855795000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass